United States Transfection Technologies Market 2021-2026: Size, Share, Trends, Analysis and Forecast Report
United States Transfection Technologies Market 2021-2026: Size, Share, Trends, Analysis and Forecast Report
Published by IMARC Services Private Limited
Posted on October 8, 2021
The United States Transfection Technologies Market is expected to exhibit moderate growth during 2021-2026. The report provides a detailed analysis of the market by Product Type, Application, Transfection Method, Technology, End User, Region.
Transfection technology refers to the method of artificially introducing various nucleic acids, such as oligonucleotides, Deoxyribonucleic Acid (DNA), and Ribonucleic Acid (RNA), into the eukaryotic cells. It can be done using biological, physical, and chemical methods, which aid in modifying specific properties of the cell. Transfection includes electroporation, cationic lipid transfection, in-vivo transfection, etc. At present, it is extensively used for numerous genomic studies, including gene expression, RNA interference, screening, etc.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The elevating number of cases of infectious diseases that require antibiotics is driving the transfection technologies market in the United States. Additionally, the rising utilization of cell-based products is also augmenting the demand for transfection methods to treat various chronic diseases, such as tuberculosis, cardiovascular diseases, cancer, etc. Moreover, several reagent-based transfection technologies, including laserfection, biolistic technology, and microinjection, are gaining traction based on their accuracy and cost-effectiveness. Besides this, numerous manufacturers are focusing on extensive R&D activities for advanced cytological studies, cancer therapeutics, and precision medicine, which are also fueling the market growth in the country. Apart from this, increasing investments by both private and government bodies to develop large-scale transfection facilities are further anticipated to bolster the United States market over the forecasted period.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact Us
Olivia Anderson Marketing Manager 30 N Gould St, Ste R Sheridan, WY 82801, USA Email: sales@imarcgroup.com Website: https://www.imarcgroup.com LinkedIn: https://in.linkedin.com/company/imarc-group
The United States Transfection Technologies Market is expected to exhibit moderate growth during 2021-2026. The report provides a detailed analysis of the market by Product Type, Application, Transfection Method, Technology, End User, Region.
Transfection technology refers to the method of artificially introducing various nucleic acids, such as oligonucleotides, Deoxyribonucleic Acid (DNA), and Ribonucleic Acid (RNA), into the eukaryotic cells. It can be done using biological, physical, and chemical methods, which aid in modifying specific properties of the cell. Transfection includes electroporation, cationic lipid transfection, in-vivo transfection, etc. At present, it is extensively used for numerous genomic studies, including gene expression, RNA interference, screening, etc.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The elevating number of cases of infectious diseases that require antibiotics is driving the transfection technologies market in the United States. Additionally, the rising utilization of cell-based products is also augmenting the demand for transfection methods to treat various chronic diseases, such as tuberculosis, cardiovascular diseases, cancer, etc. Moreover, several reagent-based transfection technologies, including laserfection, biolistic technology, and microinjection, are gaining traction based on their accuracy and cost-effectiveness. Besides this, numerous manufacturers are focusing on extensive R&D activities for advanced cytological studies, cancer therapeutics, and precision medicine, which are also fueling the market growth in the country. Apart from this, increasing investments by both private and government bodies to develop large-scale transfection facilities are further anticipated to bolster the United States market over the forecasted period.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Contact Us
Olivia Anderson Marketing Manager 30 N Gould St, Ste R Sheridan, WY 82801, USA Email: sales@imarcgroup.com Website: https://www.imarcgroup.com LinkedIn: https://in.linkedin.com/company/imarc-group